- Filed
- Aug 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jul 31, 2025 | 522.13M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 522M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 525M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 260M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 260M sh |
| Stock Repurchased | Q2 2025 · Jun 30, 2025 | $0 |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $27M |
| Dividends Paid | Q2 2025 · Jun 30, 2025 | $450M |
| Dividends Paid | Q2 2025 · Jun 30, 2024 | $335M |
| Capex | Q2 2025 · Jun 30, 2025 | $999M |
| Capex | Q2 2025 · Jun 30, 2024 | $385M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $1.06B |
| Operating Cash Flow restated | Q2 2025 · Jun 30, 2024 | $382M |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $1.03B |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $1.05B |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $778M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $855M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $18.3B |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $17.36B |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $7.59B |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $7.33B |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $27.42B |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $26.37B |
| Current Assets | Q2 2025 · Jun 30, 2025 | $10.98B |
| Current Assets | Q2 2025 · Dec 31, 2024 | $10.06B |
| Total Assets | Q2 2025 · Jun 30, 2025 | $45.75B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $43.76B |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.05 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $0.68 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | $0.51 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | $1.24 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.05 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $0.68 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | $0.51 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | $1.25 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $963M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $1.94B |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $389M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $769M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$28M |
| Net Income | Q2 2025 · Jun 30, 2025 | $356M |
| Net Income restated | Q2 2025 · Jun 30, 2024 | $132M |
| Net Income restated | Q2 2025 · Jun 30, 2024 | $323M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $251M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $804M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $244M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $551M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $1.52B |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $3.09B |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $693M |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $1.4B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $6.43B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $12.5B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $2.28B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $4.5B |
| Revenue | Q2 2025 · Jun 30, 2025 | $7.94B |
| Revenue | Q2 2025 · Jun 30, 2025 | $15.6B |
| Revenue | Q2 2025 · Jun 30, 2024 | $2.97B |
| Revenue | Q2 2025 · Jun 30, 2024 | $5.9B |